RANQUILON is being developed as a therapy for anxiety related to neurasthenia and adjustment disorders. It helps to manage symptoms of anxiety, Alzheimer’s disease or cognitive impairment.
USES
- Anxiety disorders associated with neurastenia.
- Adjustment (adaptation) disorders.
- Alzheimer desease.
GUARANTEE & EXPIRY DATE
100% original from various Russian pharmaceutical manufacturers. Product photo may vary. All packs are air tight sealed and expire up to 09.2027.
DESCRIPTION
Ranquilon is developed for the management of neurodegenerative conditions. It is primarily indicated for the treatment of Alzheimer's disease, a progressive and debilitating disorder characterized by cognitive decline, memory loss, and functional impairment. Ranquilon is used in the treatment of Alzheimer's disease helps to manage symptoms and possibly slow disease progression.
Ranquilon is a CCK1 receptor antagonist. By blocking these receptors, it reduce anxiety symptoms, as CCK1 pathways are involved in stress and anxiety responses.
Ranquilon reduced behavioral and biochemical markers of stress, such as lowering the cortisol/DHEA-S ratio, indicating reduced stress response.
PACKAGING & DOSAGE
One pack contains 60 tablets.
Active ingrediënt: GB-115 (N-(1-oxo-6-phenylhexyl)glycyl-L-tryptophanamide) 1mg.
Excipients of the core: Lactose monohydrate, maize starch, povidone, magnesium stearate, talc.
Dosage: 6 mg per day, administered as 1 mg tablets (6 tablets daily)
SIDE EFFECTS AND PRECAUTIONS
- Drowsiness.
- Fatigue.
- Gastrointestinal discomfort.
- Headache.
STORAGE
Store in dry place at room temperature. Do not exceed storage temperature higher than 25 degrees Celcius. Keep away from direct sunlight. Keep locked and away from children.
QUESTIONS?
Ask us any questions about Ranquilon.
